These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25583844)

  • 1. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.
    Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T
    Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability.
    Balnytė R; Rastenytė D; Ulozienė I; Mickevičienė D; Skordenienė E; Vitkauskienė A
    Medicina (Kaunas); 2011; 47(7):368-73. PubMed ID: 22112985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen.
    Kikuchi S; Fukazawa T; Niino M; Yabe I; Miyagishi R; Hamada T; Hashimoto SA; Tashiro K
    Neurology; 2003 Feb; 60(4):647-51. PubMed ID: 12601107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
    Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
    Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
    J Neuroimmunol; 2013 Jan; 254(1-2):170-3. PubMed ID: 22967351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
    Mero IL; Gustavsen MW; Sæther HS; Flåm ST; Berg-Hansen P; Søndergaard HB; Jensen PE; Berge T; Bjølgerud A; Muggerud A; Aarseth JH; ; Myhr KM; Celius EG; Sellebjerg F; Hillert J; Alfredsson L; Olsson T; Oturai AB; Kockum I; Lie BA; Andreassen BK; Harbo HF
    PLoS One; 2013; 8(3):e58352. PubMed ID: 23472185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
    Yoshimura S; Isobe N; Matsushita T; Masaki K; Sato S; Kawano Y; Ochi H; Kira J
    PLoS One; 2014; 9(4):e95367. PubMed ID: 24736746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
    Imrell K; Landtblom AM; Hillert J; Masterman T
    Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
    Saadatnia M; Najafi MR; Najafi F; Davoudi V; Keyhanian K; Maghzi AH
    Neuroimmunomodulation; 2012; 19(3):195-9. PubMed ID: 22262195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
    Balnyte R; Rastenyte D; Vaitkus A; Mickeviciene D; Skrodeniene E; Vitkauskiene A; Uloziene I
    BMC Neurol; 2013 Jul; 13():77. PubMed ID: 23837503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new risk variant for multiple sclerosis at the immunoglobulin heavy chain locus associates with intrathecal IgG, IgM index and oligoclonal bands.
    Delgado-García M; Matesanz F; Alcina A; Fedetz M; García-Sánchez MI; Ruiz-Peña JL; Fernández Ó; Pinto Medel MJ; Leyva L; Arnal C; Delgado C; López Guerrero JA; González-Pérez A; Sáez ME; Villar LM; Álvarez-Cermeño JC; Picón C; Arroyo R; Varadé J; Urcelay E; Izquierdo G; Lucas M
    Mult Scler; 2015 Aug; 21(9):1104-11. PubMed ID: 25392328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoclonal bands: An immunological and clinical approach.
    Cabrera CM
    Adv Clin Chem; 2022; 109():129-163. PubMed ID: 35953125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
    Goris A; Pauwels I; Gustavsen MW; van Son B; Hilven K; Bos SD; Celius EG; Berg-Hansen P; Aarseth J; Myhr KM; D'Alfonso S; Barizzone N; Leone MA; Martinelli Boneschi F; Sorosina M; Liberatore G; Kockum I; Olsson T; Hillert J; Alfredsson L; Bedri SK; Hemmer B; Buck D; Berthele A; Knier B; Biberacher V; van Pesch V; Sindic C; Bang Oturai A; Søndergaard HB; Sellebjerg F; Jensen PE; Comabella M; Montalban X; Pérez-Boza J; Malhotra S; Lechner-Scott J; Broadley S; Slee M; Taylor B; Kermode AG; Gourraud PA; ; Sawcer SJ; Andreassen BK; Dubois B; Harbo HF
    Brain; 2015 Mar; 138(Pt 3):632-43. PubMed ID: 25616667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.